Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease.
Publication/Presentation Date
9-1-2015
Volume
63
Issue
3
First Page
763
Last Page
765
ISSN
1600-0641
Published In/Presented At
Bhamidimarri, K. R., Czul, F., Peyton, A., Levy, C., Hernandez, M., Jeffers, L., Roth, D., Schiff, E., O'Brien, C., & Martin, P. (2015). Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease. Journal of hepatology, 63(3), 763–765. https://doi.org/10.1016/j.jhep.2015.06.004
Disciplines
Medicine and Health Sciences
PubMedID
26095179
Department(s)
Department of Medicine
Document Type
Article
COinS